Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (251-260 of 13,976) with videos related to

Pageof 1,398
Sort By:
Leukemia|August 24, 2019
New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical modelsJulie A Hixon, Caroline Andrews, Lila Kashi, et al.
Leukemia|October 6, 2019
In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding siteAnuhar Chaturvedi, Ramya Goparaju, Charu Gupta, et al.
Leukemia|October 9, 2019
Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19Mukta Asnani, Katharina E Hayer, Ammar S Naqvi, et al.
Leukemia|February 2, 2021
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemiaBruno Paiva, María-Belen Vidriales, Amparo Sempere, et al.
Leukemia|February 2, 2021
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinibH Yesid Estupiñán, Qing Wang, Anna Berglöf, et al.
Leukemia|February 2, 2021
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4<sup>+</sup> T cells in chronic lymphocytic leukemiaPhilipp M Roessner, Laura Llaó Cid, Ekaterina Lupar, et al.
Leukemia|February 5, 2021
Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMTJordi Esteve, Sebastian Giebel, Myriam Labopin, et al.
Leukemia|February 5, 2021
Menin is necessary for long term maintenance of meningioma-1 driven leukemiaClara Libbrecht, Hongbo M Xie, Molly C Kingsley, et al.
Leukemia|January 6, 2022
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) AmyloidosisSriram Ravichandran, Steven Law, Shameem Mahmood, et al.
Leukemia|January 18, 2022
HMCES safeguards genome integrity and long-term self-renewal of hematopoietic stem cells during stress responsesYinghao Pan, Hongna Zuo, Fei Wen, et al.
Pageof 1,398

Showing results (251-260 of 13,976) with videos related to

Sort By:
Pageof 1,398
Leukemia|August 24, 2019
New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical modelsJulie A Hixon, Caroline Andrews, Lila Kashi, et al.
Leukemia|October 6, 2019
In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding siteAnuhar Chaturvedi, Ramya Goparaju, Charu Gupta, et al.
Leukemia|October 9, 2019
Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19Mukta Asnani, Katharina E Hayer, Ammar S Naqvi, et al.
Leukemia|February 2, 2021
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemiaBruno Paiva, María-Belen Vidriales, Amparo Sempere, et al.
Leukemia|February 2, 2021
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinibH Yesid Estupiñán, Qing Wang, Anna Berglöf, et al.
Leukemia|February 2, 2021
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4<sup>+</sup> T cells in chronic lymphocytic leukemiaPhilipp M Roessner, Laura Llaó Cid, Ekaterina Lupar, et al.
Leukemia|February 5, 2021
Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMTJordi Esteve, Sebastian Giebel, Myriam Labopin, et al.
Leukemia|February 5, 2021
Menin is necessary for long term maintenance of meningioma-1 driven leukemiaClara Libbrecht, Hongbo M Xie, Molly C Kingsley, et al.
Leukemia|January 6, 2022
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) AmyloidosisSriram Ravichandran, Steven Law, Shameem Mahmood, et al.
Leukemia|January 18, 2022
HMCES safeguards genome integrity and long-term self-renewal of hematopoietic stem cells during stress responsesYinghao Pan, Hongna Zuo, Fei Wen, et al.
Pageof 1,398